Corcept Therapeutics Incorporated (CORT) — Financial Flexibility Index
Corcept Therapeutics Incorporated (CORT) has a Financial Flexibility Index of -0.09x as of March 2026. Free cash flow of $-16.57 Million (operating CF $-16.77 Million minus capex $201.00K) represents 0% of total liabilities ($176.89 Million). Check Corcept Therapeutics Incorporated cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Corcept Therapeutics Incorporated Financial Flexibility Index (2003–2025)
Historical Financial Flexibility Index trend for Corcept Therapeutics Incorporated across 23 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Corcept Therapeutics Incorporated.
Annual Financial Flexibility Index for Corcept Therapeutics Incorporated (2003–2025)
Year-by-year free cash flow to debt coverage for Corcept Therapeutics Incorporated. Explore Corcept Therapeutics Incorporated (CORT) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.75x | $142.21 Million | $142.00 Million | $188.85 Million | ▼ -39.5% |
| 2024 | 1.24x | $200.24 Million | $198.07 Million | $160.96 Million | ▲ +12.3% |
| 2023 | 1.11x | $127.18 Million | $127.04 Million | $114.81 Million | ▼ -25.1% |
| 2022 | 1.48x | $120.74 Million | $120.32 Million | $81.59 Million | ▼ -57.9% |
| 2021 | 3.51x | $168.36 Million | $167.89 Million | $47.95 Million | ▲ +10.9% |
| 2020 | 3.17x | $153.21 Million | $151.97 Million | $48.39 Million | ▼ -5.1% |
| 2019 | 3.34x | $137.21 Million | $136.12 Million | $41.13 Million | ▲ +3.0% |
| 2018 | 3.24x | $115.96 Million | $115.67 Million | $35.81 Million | ▲ +56.1% |
| 2017 | 2.07x | $61.35 Million | $60.94 Million | $29.57 Million | ▲ +205.6% |
| 2016 | 0.68x | $18.59 Million | $18.39 Million | $27.37 Million | ▲ +621.4% |
| 2015 | 0.09x | $3.15 Million | $3.13 Million | $33.44 Million | ▲ +113.2% |
| 2014 | -0.72x | $-27.20 Million | $-27.38 Million | $38.02 Million | ▲ +18.5% |
| 2013 | -0.88x | $-36.93 Million | $-37.06 Million | $42.06 Million | ▲ +8.5% |
| 2012 | -0.96x | $-35.87 Million | $-36.02 Million | $37.39 Million | ▲ +82.4% |
| 2011 | -5.45x | $-27.38 Million | $-27.40 Million | $5.03 Million | ▲ +5.7% |
| 2010 | -5.77x | $-22.29 Million | $-22.29 Million | $3.86 Million | ▲ +22.2% |
| 2009 | -7.42x | $-17.96 Million | $-17.97 Million | $2.42 Million | ▼ -16.0% |
| 2008 | -6.40x | $-18.36 Million | $-18.36 Million | $2.87 Million | ▼ -75.7% |
| 2007 | -3.64x | $-10.96 Million | $-10.96 Million | $3.01 Million | ▲ +41.1% |
| 2006 | -6.19x | $-21.92 Million | $-23.24 Million | $3.54 Million | ▼ -355.6% |
| 2005 | 2.42x | $8.63 Million | $-17.23 Million | $3.56 Million | ▼ -95.1% |
| 2004 | 49.44x | $90.18 Million | $-13.72 Million | $1.82 Million | ▲ +860.0% |
| 2003 | -6.51x | $-10.00 Million | $-10.00 Million | $1.54 Million | — |